Cleared Traditional

K972342 - REAADS PROTEIN C ANTIGEN TEST KIT

K972342 is an FDA 510(k) clearance for REAADS PROTEIN C ANTIGEN TEST KIT, manufactured by Reaads Medical Products, Inc.. The device is a Class 2 Hematology device with product code GGP cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K972342 · Reaads Medical Products, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
104d
Days
Class 2
Risk

K972342 is an FDA 510(k) clearance for the REAADS PROTEIN C ANTIGEN TEST KIT. Classified as Test, Qualitative And Quantitative Factor Deficiency (product code GGP), Class II - Special Controls.

Submitted by Reaads Medical Products, Inc. (Westminister, US). The FDA issued a Cleared decision on October 6, 1997 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Reaads Medical Products, Inc. devices

FDA 510(k) Submission Details - K972342

510(k) Number K972342 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 1997
Decision Date October 06, 1997
Days to Decision 104 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 113d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGP Device Classification - Class 2, Special Controls

Product Code GGP Test, Qualitative And Quantitative Factor Deficiency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGP Test, Qualitative And Quantitative Factor Deficiency

All 156
Devices cleared under the same product code (GGP) and FDA review panel - the closest regulatory comparables to K972342.
IL TEST PROTEIN C
K980875 · Instrumentation Laboratory CO · Apr 1998
COAMATIC FACTOR VIII
K981038 · Instrumentation Laboratory CO · Apr 1998
N-ASSAY TIA PLASMINOGEN TEST KIT
K971985 · Crestat Diagnostics, Inc. · Oct 1997
UNIVERSAL REAGENT FACTOR XII (TWELVE) DEFICIENT PLASMA
K973143 · Universal Reagents, Inc. · Sep 1997
ASSERACHROM TPA TEST KIT
K971519 · American Bioproducts Co. · Aug 1997
REAADS VON WILLEBRAND FACTOR ANTIGEN TEST KIT
K972005 · Reaads Medical Products, Inc. · Aug 1997